HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus itself, offering hope for future gene therapy without daily meds.

An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, held its 2025 Annual Shareholders' Meeting today, chaired by Chairman Mr. Benny T. Hu. The company delivered updates ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

Medical tests on the Bangladeshi women rescued recently from an inter-state prostitution racket operating across the city ...

In a significant breakthrough, scientists at Johns Hopkins University have discovered that gene therapy could be a key to forcing HIV into a permanent dormant state, potentially offering a long-term, ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...